EFTA Document EFTA01453915

As of 4/23/14 11:34 pm Description Trade Date Quantity Current Price Unit Cost Market value Current Total Cost Unrealized G/L SANGAMO BIOSCIENCES 5/28/2013 50,000.00 $ 14.17 $ 8.44 $ 708,500.00 422,214.00 $ 286,286.00 BIOGEN 2/14/2012 2,095.00 $ 300.61 $ 119.55 $ 629,786.33 250,454.95 $ 379,331.38 FOUNDATION MEDICINE 1/13/2014 25,000.00 $ 26.74 $ 27.51 $ 668,500.00 687,663.50 $ (19,163.50) GILEAD SCIENCES INC Multiple 8,100.00 $ 74.93 $ 79.41 $ 606,932.19 643,204.00 5 (36,271.81) ARIAD PHARMACEUTICALS Multiple 16,535.00 $ 7.58 $ 17.60 $ 125,333.65 290,997.40 $ (165,663.75) Total Biotech $ 2,739,052.17 $ 2,294,533.85 $ 444,518.32 PX_LAST CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0111771 SDNY_GM_00257955 EFTA01453915